v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
Common Shares
Additional paid-in Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Total
Balance at beginning of period at Dec. 31, 2024 $ 116,081,031 $ 12,118,907 $ 10,033,267 $ (41,505,076) $ 96,728,129
Balance (in shares) at Dec. 31, 2024 22,008,766        
Increase (Decrease) in Stockholders' Equity          
Net income (loss)       4,016,034 4,016,034
Dividends paid       (1,375,612) (1,375,612)
Stock-based compensation expense   385,838     385,838
Other comprehensive (loss) income     (50,116)   (50,116)
Balance at end of period at Mar. 31, 2025 $ 116,081,031 12,504,745 9,983,151 (38,864,654) 99,704,273
Balance (in shares) at Mar. 31, 2025 22,008,766        
Balance at beginning of period at Dec. 31, 2024 $ 116,081,031 12,118,907 10,033,267 (41,505,076) 96,728,129
Balance (in shares) at Dec. 31, 2024 22,008,766        
Balance at end of period at Jun. 30, 2025 $ 116,081,031 12,890,583 9,907,655 (38,688,953) 100,190,316
Balance (in shares) at Jun. 30, 2025 22,017,405        
Balance at beginning of period at Mar. 31, 2025 $ 116,081,031 12,504,745 9,983,151 (38,864,654) 99,704,273
Balance (in shares) at Mar. 31, 2025 22,008,766        
Increase (Decrease) in Stockholders' Equity          
Net income (loss)       1,551,461 1,551,461
Dividends paid       (1,375,760) (1,375,760)
Stock-based compensation expense   385,838     385,838
Vesting of shares of restricted stock (in shares) 8,639        
Other comprehensive (loss) income     (75,496)   (75,496)
Balance at end of period at Jun. 30, 2025 $ 116,081,031 12,890,583 9,907,655 (38,688,953) 100,190,316
Balance (in shares) at Jun. 30, 2025 22,017,405        
Balance at beginning of period at Dec. 31, 2025 $ 154,274,125 13,863,824 9,896,567 (53,302,162) 124,732,354
Balance (in shares) at Dec. 31, 2025 30,239,980        
Increase (Decrease) in Stockholders' Equity          
Net income (loss)       729,425 729,425
Dividends paid       (1,884,373) (1,884,373)
Stock-based compensation expense   547,527     547,527
Other comprehensive (loss) income     (2,319)   (2,319)
Balance at end of period at Mar. 31, 2026 $ 154,274,125 14,411,351 9,894,248 (54,457,110) 124,122,614
Balance (in shares) at Mar. 31, 2026 30,239,980        
Balance at beginning of period at Dec. 31, 2025 $ 154,274,125 13,863,824 9,896,567 (53,302,162) 124,732,354
Balance (in shares) at Dec. 31, 2025 30,239,980        
Balance at end of period at Jun. 30, 2026 $ 154,274,125 14,958,878 9,892,216 (49,214,176) 129,911,043
Balance (in shares) at Jun. 30, 2026 30,248,617        
Balance at beginning of period at Mar. 31, 2026 $ 154,274,125 14,411,351 9,894,248 (54,457,110) 124,122,614
Balance (in shares) at Mar. 31, 2026 30,239,980        
Increase (Decrease) in Stockholders' Equity          
Net income (loss)       7,133,471 7,133,471
Dividends paid       (1,890,537) (1,890,537)
Stock-based compensation expense   547,527     547,527
Vesting of shares of restricted stock (in shares) 8,637        
Other comprehensive (loss) income     (2,032)   (2,032)
Balance at end of period at Jun. 30, 2026 $ 154,274,125 $ 14,958,878 $ 9,892,216 $ (49,214,176) $ 129,911,043
Balance (in shares) at Jun. 30, 2026 30,248,617